Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 20,000 shares at $92.07 ($1.8M) on 2019-07-30, disclosed to the SEC on 2019-07-31.
Open-market sale of $1.8M NBIX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.07 | 10,000 | $921K | 50.0% |
| 2 | $92.07 | 10,000 | $921K | 50.0% |
| Total | $92.07 avg | 20,000 | $1.8M | 100% |
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-08-15 | $3.5M | — | Filing → |